Member Info for JOHNO77

Closing on HOD very nice

Looking like a cracking end of the week in store for N4

nuvec will take us back to new highs Mazik IMO. Last Rns strongly indicating Medimmune will agree terms on which they will develop an optimised version of nuvec: “MedImmune has confirmed its committment to investigating non-lipid nanoparticle technologies for mRNA and pDNA delivery and its intention to continue to work with N4 Pharma to conduct further ongoing research with a view to agreeing terms for co-development of an optimised version of Nuvec® under an appropriate collaboration agreement” Making the move from traders dream to investors dream. DYOR

Just checked in as out of signal. Looking very good lads.

Yes agreed Cam, got some at 5.45 & 5.75 so v happy with that. Decent cash levels vs mcap and lots of news in the pipeline so looks like it's got a great chance of making moves over the next weeks / months.

Blimey we have life in the BB :0)

Wonder how NT is getting on in Denmark? Expect plenty of potential partners will be keen to talk to us what with our new data set and our ringing endorsement from Medimmune....

:)

Have posted this before but worth a look at some recent Medimmune collaboration deals....Gives an idea of the potential involved when Medimmune like what they see in a product...

1. Innovio Pharmaceuticals - cancer vaccine collaboration ongoing, started Aug 15. At that stage their product was only a phase 1 clinical trial stage...
$27.5mill upfront - milestone payments up to $700m.

http://ir.inovio.com/news-and-media/news/press-release-details/2015/Inovio-Pharmaceuticals-Enters-Into-Strategic-Cancer-Vaccine-Collaboration-and-License-Agreement-With-MedImmune/default.aspx

2. Innate Pharma - co development & commercial agreement for antibody product.
Initial $250m upfront, milestone payments up to $925m
(They received 41.6mill euros during 2016 and 32.3mill euros during 2017)

https://www.innate-pharma.com/en/news-events/press-releases/innate-pharma-and-astrazeneca-announce-global-co-development-and-commercialisation-agreement-iph2201-immuno-oncology

3. Compugen - Licensing agreement for its antibody products
$10mill upfront - up to $200m in milestone payments

https://www.cgen.com/wp-content/uploads/MEDI-CGEN-PR-FINAL-04022018.pdf

This is substantial news guys.

SP will rerate from here IMO.

Well done guys.

RNS basically saying we are pretty much there with Medimmune and together we'll be looking at developing an optimised version of Nuvec® under an appropriate collaboration agreement with them (AstraZeneca!!!!).

Thats not a ramp it's just where we are - against a 5mill mcap, lol.

Can't believe how quiet BB is! People missing late RNS or people scrambling for shares?

Think there's a few trying to buy at the mo.... :)

GLA

Great news this morning :)

The Company is pleased to announce that MedImmune has confirmed its committment to investigating non-lipid nanoparticle technologies for mRNA and pDNA delivery and its intention to continue to work with N4 Pharma to conduct further ongoing research with a view to agreeing terms for co-development of an optimised version of Nuvec® under an appropriate collaboration agreement.

Actually considering we are on the cusp of proper company making news with Medimmune the risk reward ratio on this is outstanding from a <5m mcap.

55p sounds nice, has a ring to it. Maziks 40m mcap target is very feasible and possibly not too far away should a licensing deal come through...

The price is almost on it's knees and we are closer than ever to Nuvec success.

The next 3-4 months here could be huge for N4P. We are hearing all the right sounds from the Medimmune collaboration...……...

Nominated already in top 20 tech innovations 2018. Am intrigued by this one, took speculative position last week. Has potential to be absolutely huge IF it takes off. Let’s face it everyone lives eating out. Huge market. Huge scope for ££’s in app advertising.

Yes this has the potential to open up many doors for us Vander. From the sounds of it the Medimmune collab has gone very well but it’s important to remember that the business model is MULTIPLE partners, multiple licenses for multiples of products.

No surprise to see buyers coming in. 5p will be long gone soon biggyie IMO

Good find Leister. NT will be much better equipped with the latest data obtained from this years work.

'We are building a compelling data package to aide our commercial collaboaration discussions which we continue to progress."

Good times ahead for N4P imo.

Agreed - Take the chance to load up biggyie, I have.

Great update. Thing progressing very very well it seems...